0001127602-13-030657.txt : 20131105 0001127602-13-030657.hdr.sgml : 20131105 20131105170247 ACCESSION NUMBER: 0001127602-13-030657 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131104 FILED AS OF DATE: 20131105 DATE AS OF CHANGE: 20131105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alkermes plc. CENTRAL INDEX KEY: 0001520262 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981007018 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN 2 STATE: L2 ZIP: 00000 BUSINESS PHONE: 00-353-1-649-2000 MAIL ADDRESS: STREET 1: TREASURY BUILDING STREET 2: LOWER GRAND CANAL STREET CITY: DUBLIN 2 STATE: L2 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC DATE OF NAME CHANGE: 20110804 FORMER COMPANY: FORMER CONFORMED NAME: Antler Science Two Ltd DATE OF NAME CHANGE: 20110509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Botkin James L CENTRAL INDEX KEY: 0001529873 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35299 FILM NUMBER: 131193428 MAIL ADDRESS: STREET 1: 33 NORTHEAST COVE ROAD CITY: DAWSONVILLE STATE: GA ZIP: 30534 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-11-04 0001520262 Alkermes plc. ALKS 0001529873 Botkin James L 1300 GOULD DRIVE GAINESVILLE GA 30504 1 SVP, Alkermes Gainesville LLC Ordinary Shares 2013-11-04 4 M 0 11000 14.60 A 13509 D Ordinary Shares 2013-11-04 4 S 0 11000 35.4432 D 2509 D Employee Stock Option (Right to Buy) 14.60 2013-11-04 4 M 0 11000 0 D 2012-10-05 2021-10-05 Ordinary Shares 11000 67000 D This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.245 to $35.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The option becomes exercisable in three annual installments: 33,000 vesting on 10/5/2012, 33,000 vesting on 10/5/2013 and 34,000 vesting on 10/5/2014. /s/ Jennifer Baptiste, attorney-in-fact for James L Botkin 2013-11-05